The 2023 initiative by the US Army Medical Research and Development Command (MRDC) and Medical Technology Enterprise Consortium (MTEC) has renewed its efforts from previous projects while bringing original ideas and the latest technologies to the research. The goal is to bring measurable acceleration to clinical products through robust partnerships.
Abstracts
The abstracts and projects listed below are sponsored by the US Government under MTEC Research Project Award: MTEC-23-04-AFIRM-004. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright notation thereon.
Clinical Therapies
The team will focus on developing clinical therapies over the next 5 years in the areas of: